🎗️ June is Uterine Cancer Awareness Month. These cancers include endometrial cancers and uterine sarcomas.

Did you know that endometrial cancer is the most common gynecologic cancer in the U.S., projected to affect over 69,000 women and cause nearly 14,000 deaths in 2025, according to the American Cancer Society
🧬 In March 2025, researchers at the Icahn School of Medicine at Mount Sinai made a breakthrough discovery, identifying specific blood proteins (biomarkers) that may predict how patients respond to a combination of two cancer drugs.
🔬 This is the first study to examine blood-based biomarkers for predicting treatment outcomes in endometrial cancer, paving the way for more personalized and effective therapies.
💡 These findings offer new hope for tailoring treatment strategies and improving outcomes for women facing endometrial cancer.

Clinakos Inc. proudly supports all efforts to raise awareness, encourage early detection, and empower women with knowledge to drive progress in care.
See the link to the original article in the comments below 👇

👉Reach out to us to learn more at https://lnkd.in/gp3gUmXc
👉Follow us at Clinakos Inc.